Structural and Functional Characterization of the Dimerization Sites of Soluble Guanylyl Cyclase

Z. Zhou, Ch Roussos, Andreas Papapetropoulos

Research output: Contribution to journalArticle

Abstract

Soluble guanylyl cyclase (sGC) is a ubiquitous enzyme that functions as a receptor for nitric oxide. In spite of the obligate heterodimeric nature of sGC, the sequence mediating subunit association have remained elusive. Our initial screening for the interaction site(s) demonstrated that two regions of each subunit, i.e. the regulatory domain and the central region, are involved in heterodimer formation of the most common sGC isoenzyme, α 11. To precisely map the relevant segments in the β1 subunit, we constructed multiple N- and C-terminal deletion variants and co-transfected them with full-length α1 in COS cells. Immunoprecipitation revealed that a sequence segment spanning positions 204 to 408 mediates binding of α1 to β1. Fusion of the α1 dimerization region to EGFP conferred binding activity to the recipient protein. Analysis of deletion constructs lacking portions of the dimerization region identified two distinct sites in β 1 that contribute importantly to its interaction with α 1, i.e. an N-terminal binding site (NBS) covering positions 204 to 244 and a C-terminal binding site at 379 to 408 (CBS). Both NBS and CBS are crucial for sGC function as deletion of either site rendered sGC inactive. We conclude that the dimerization region of β1 extends over 205 residues of its regulatory and central domains, and that two discontinuous sites of 41 and 30 residues, respectively facilitate binding of β 1 to the α1 subunit of sGC.

Original languageEnglish (US)
Pages (from-to)36-38
Number of pages3
JournalReview of Clinical Pharmacology and Pharmacokinetics, International Edition
Volume18
Issue number1
StatePublished - Mar 19 2004
Externally publishedYes

Fingerprint

Dimerization
Binding Sites
COS Cells
Soluble Guanylyl Cyclase
Immunoprecipitation
Isoenzymes
Enzymes
Proteins

ASJC Scopus subject areas

  • Pharmacology (medical)

Cite this

@article{3e905b67e97746518ce20f6061895ba0,
title = "Structural and Functional Characterization of the Dimerization Sites of Soluble Guanylyl Cyclase",
abstract = "Soluble guanylyl cyclase (sGC) is a ubiquitous enzyme that functions as a receptor for nitric oxide. In spite of the obligate heterodimeric nature of sGC, the sequence mediating subunit association have remained elusive. Our initial screening for the interaction site(s) demonstrated that two regions of each subunit, i.e. the regulatory domain and the central region, are involved in heterodimer formation of the most common sGC isoenzyme, α 1/β1. To precisely map the relevant segments in the β1 subunit, we constructed multiple N- and C-terminal deletion variants and co-transfected them with full-length α1 in COS cells. Immunoprecipitation revealed that a sequence segment spanning positions 204 to 408 mediates binding of α1 to β1. Fusion of the α1 dimerization region to EGFP conferred binding activity to the recipient protein. Analysis of deletion constructs lacking portions of the dimerization region identified two distinct sites in β 1 that contribute importantly to its interaction with α 1, i.e. an N-terminal binding site (NBS) covering positions 204 to 244 and a C-terminal binding site at 379 to 408 (CBS). Both NBS and CBS are crucial for sGC function as deletion of either site rendered sGC inactive. We conclude that the dimerization region of β1 extends over 205 residues of its regulatory and central domains, and that two discontinuous sites of 41 and 30 residues, respectively facilitate binding of β 1 to the α1 subunit of sGC.",
author = "Z. Zhou and Ch Roussos and Andreas Papapetropoulos",
year = "2004",
month = "3",
day = "19",
language = "English (US)",
volume = "18",
pages = "36--38",
journal = "Review of Clinical Pharmacology and Pharmacokinetics, International Edition",
issn = "1011-6583",
publisher = "PHARMAKON-Press",
number = "1",

}

TY - JOUR

T1 - Structural and Functional Characterization of the Dimerization Sites of Soluble Guanylyl Cyclase

AU - Zhou, Z.

AU - Roussos, Ch

AU - Papapetropoulos, Andreas

PY - 2004/3/19

Y1 - 2004/3/19

N2 - Soluble guanylyl cyclase (sGC) is a ubiquitous enzyme that functions as a receptor for nitric oxide. In spite of the obligate heterodimeric nature of sGC, the sequence mediating subunit association have remained elusive. Our initial screening for the interaction site(s) demonstrated that two regions of each subunit, i.e. the regulatory domain and the central region, are involved in heterodimer formation of the most common sGC isoenzyme, α 1/β1. To precisely map the relevant segments in the β1 subunit, we constructed multiple N- and C-terminal deletion variants and co-transfected them with full-length α1 in COS cells. Immunoprecipitation revealed that a sequence segment spanning positions 204 to 408 mediates binding of α1 to β1. Fusion of the α1 dimerization region to EGFP conferred binding activity to the recipient protein. Analysis of deletion constructs lacking portions of the dimerization region identified two distinct sites in β 1 that contribute importantly to its interaction with α 1, i.e. an N-terminal binding site (NBS) covering positions 204 to 244 and a C-terminal binding site at 379 to 408 (CBS). Both NBS and CBS are crucial for sGC function as deletion of either site rendered sGC inactive. We conclude that the dimerization region of β1 extends over 205 residues of its regulatory and central domains, and that two discontinuous sites of 41 and 30 residues, respectively facilitate binding of β 1 to the α1 subunit of sGC.

AB - Soluble guanylyl cyclase (sGC) is a ubiquitous enzyme that functions as a receptor for nitric oxide. In spite of the obligate heterodimeric nature of sGC, the sequence mediating subunit association have remained elusive. Our initial screening for the interaction site(s) demonstrated that two regions of each subunit, i.e. the regulatory domain and the central region, are involved in heterodimer formation of the most common sGC isoenzyme, α 1/β1. To precisely map the relevant segments in the β1 subunit, we constructed multiple N- and C-terminal deletion variants and co-transfected them with full-length α1 in COS cells. Immunoprecipitation revealed that a sequence segment spanning positions 204 to 408 mediates binding of α1 to β1. Fusion of the α1 dimerization region to EGFP conferred binding activity to the recipient protein. Analysis of deletion constructs lacking portions of the dimerization region identified two distinct sites in β 1 that contribute importantly to its interaction with α 1, i.e. an N-terminal binding site (NBS) covering positions 204 to 244 and a C-terminal binding site at 379 to 408 (CBS). Both NBS and CBS are crucial for sGC function as deletion of either site rendered sGC inactive. We conclude that the dimerization region of β1 extends over 205 residues of its regulatory and central domains, and that two discontinuous sites of 41 and 30 residues, respectively facilitate binding of β 1 to the α1 subunit of sGC.

UR - http://www.scopus.com/inward/record.url?scp=1542320054&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=1542320054&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:1542320054

VL - 18

SP - 36

EP - 38

JO - Review of Clinical Pharmacology and Pharmacokinetics, International Edition

JF - Review of Clinical Pharmacology and Pharmacokinetics, International Edition

SN - 1011-6583

IS - 1

ER -